Biopol Chemicals Ltd (BIOPOL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Biopol Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
BIOPOL CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Biopol Chemicals to Consider Half-Yearly Financial Results on 5th Nov'26 Biopol Chemicals Limited has scheduled its Board of Directors meeting for 5th Nov'26. The primary agenda is to inter-alia consider and approve the company's unaudited financial results for the half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 05 Nov 2026, 5:30 am
Biopol Chemicals Schedules Board Meeting for Half-Year Financial Results Biopol Chemicals Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the unaudited financial results and Limited Review Report for the half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for designated insiders and will reopen 48 hours following the declaration of the financial results, per SEBI insider trading regulations.
Non-Applicability of Corporate Governance Report under Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter and Half Year ended September 30, 2026.
Others (Uncategorized) · 10 Oct 2026, 9:43 pm
Biopol Chemicals Reports Exemption From Q2FY27 Corporate Governance Filings Biopol Chemicals confirmed that corporate governance reporting under Regulation 27(2) of SEBI LODR is non-applicable for the quarter and half-year ended 30th Sep'26 due to its listing on the NSE SME Exchange. However, Regulation 23 governing Related Party Transactions has become applicable as the firm's paid-up equity capital exceeded ₹10 crore and net worth surpassed ₹25 crore as of 31st Mar'26. The company maintains an approved RPT policy alongside an active Audit Committee to ensure statutory compliance within prescribed timelines.
Voting Results in respect of the 03rd Annual General Meeting of the Company along with the Scrutinizer's Report.
Annual General Meeting · 24 Sept 2026, 10:39 pm
Biopol Chemicals Limited has informed the Exchange about Regularisation of appointment of Mr. Sukhomoy Das (DIN: 11761165) as an Independent Director of the Company for a first term of five consecutive years
Others (Uncategorized) · 23 Sept 2026, 12:01 am
Biopol Chemicals Regularises Dr. Sukhomoy Das as Independent Director Biopol Chemicals Limited announced that its shareholders regularised the appointment of Dr. Sukhomoy Das (DIN: 11761165) as an Independent Director at the AGM on 22nd Sep'26. Appointed as an Additional Director effective 11th Jun'26, Dr. Das will serve a five-year term ending 10th Jun'31, not liable to retire by rotation. He brings over 30 years of healthcare leadership, governance, and risk oversight experience from NHS Scotland. Dr. Das holds no relations to other directors and is not debarred by SEBI or any regulatory authority.
Biopol Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026 at 02:00 P.M. IST, through video conferencing and other audio-visual means via ZOOM Platform.
Annual General Meeting · 22 Sept 2026, 11:58 pm
Biopol Chemicals Limited has informed the Exchange regarding 'Participation in 53rd Dye+Chem Bangladesh 2026 INT L Expo'.
Others (Uncategorized) · 05 Sept 2026, 11:45 pm
Biopol Chemicals Participates in 53rd Dye+Chem Bangladesh 2026 International Expo Biopol Chemicals Limited announced its participation in the 53rd Dye+Chem Bangladesh 2026 INT'L Expo held in Dhaka, Bangladesh, from 2nd Sep'26 to 5th Sep'26. The company submitted the regulatory disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, highlighting its presence and industry engagement at the international exhibition.
Biopol Chemicals Limited has informed the Exchange about General Updates i.e. Clarification with respect to significant movement in price of our Company''s security.
Others (Uncategorized) · 31 Aug 2026, 4:16 pm
Biopol Chemicals Attributes Share Price Movement to Market Factors In a response to the NSE dated Aug 31, '26, regarding significant price movement, Biopol Chemicals confirmed it has not withheld any material information. The company stated that the price movement is attributable to market sentiment, demand-supply dynamics, and investor trading activity. Management asserted it has no connection with, control over, or role in the share price behavior. Biopol will continue to comply with SEBI disclosure requirements under Regulation 30.
Significant movement in price has been observed in Biopol Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Others (Uncategorized) · 28 Aug 2026, 11:30 pm
Biopol Chemicals Limited has informed the Exchange about Dispatch Of Letter With Web-Link Of Annual Report For Financial Year 2025-26 to the Shareholders whose e-mail addresses are not registered with the Company
Annual Report · 27 Aug 2026, 12:01 am
Biopol Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026 at 02:00 P.M. IST through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM )
Annual General Meeting · 26 Aug 2026, 11:44 pm
Biopol Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 25, 2026.
Outcome · 25 Aug 2026, 10:30 pm
Biopol Chemicals Sets AGM, Approves Director Appointments and Auditors Biopol Chemicals' Board met on 25-Aug-26 to approve key agenda items for the upcoming Annual General Meeting. The 3rd AGM is scheduled for 22-Sep-26 via video conference. The board approved the re-appointment of Whole-Time Director Vedant Sarkar and the regularization of Sukhomoy Das as an Independent Director for five years. Furthermore, M.K Chokshi & Associates was appointed as Secretarial Auditor and Nikhar Agarwal & Co. as Internal Auditor for FY 2026-27. Material related party transactions were also approved.
Biopol Chemicals Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 24 Aug 2026, 10:46 pm
Biopol Chemicals Limited has informed the Exchange regarding Cessation of Mrs Vandan Vij Sarkar as Non- Executive Director of the company w.e.f. August 24, 2026.
Change in Management · 24 Aug 2026, 6:07 pm
Biopol Chemicals Director Resigns Citing Other Engagements Biopol Chemicals (NSE: BIOPOL) announced the resignation of Mrs. Vandan Vij Sarkar (DIN: 02198810) from her position as Non-Executive Non-Independent Director, effective 24th Aug'26. The company filing states the reason for resignation is due to other professional engagements and commitments. The director's resignation letter confirms there are no other material reasons for her departure. The Board acknowledged her contributions during her tenure.
Biopol Chemicals Limited has informed regarding Submission of the Non-Applicability of Corporate Governance Report for the quarter ended June 30, 2026.
Others (Uncategorized) · 13 Jul 2026, 10:31 pm
Biopol Chemicals Exempt from Corporate Governance Report for Q1 FY27 Biopol Chemicals Limited, listed on the NSE SME Exchange, confirmed that the Corporate Governance Report submission under SEBI Regulation 27 is not applicable for the quarter ended 30 Jun'26. However, SEBI Regulation 23 concerning Related Party Transactions is now applicable as its paid-up equity capital exceeded ₹10 Crore and net worth surpassed ₹25 Crore as of 31 Mar'26. The company will comply with Regulation 23 requirements and has an approved RPT policy and Audit Committee in place.